A. Dattola, “Evaluating the Efficacy of Bimekizumab Across Different Sensitive Areas in Moderate-to-Severe Psoriasis: 52-week Multicentric Real-Life Experience in Lazio, Italy”, Dermatol Pract Concept, vol. 15, no. 2, p. 4976 , Apr. 2025, doi: 10.5826/dpc.1502a4976.